Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
Environment International|July 21, 2019
Urinary thiodiglycolic acid is associated with increased risk of non-alcoholic fatty liver disease in children living near a petrochemical complexChih-Wen Wang, Hung-Yi Chuang, Kai-Wei Liao, et al.International Journal of Hygiene and Environmental Health|December 1, 2019
Phthalate exposure increased the risk of early renal impairment in Taiwanese without type 2 diabetes mellitusJung-Wei Chang, Kai-Wei Liao, Chien-Yuan Huang, et al.Bioorganic & Medicinal Chemistry|August 4, 2014
Discovery, structure-activity relationship studies, and anti-nociceptive effects of 1-phenyl-3,6,6-trimethyl-1,5,6,7-tetrahydro-4H-indazol-4-one as novel opioid receptor agonistsMing-Fu Cheng, Li-Chin Ou, Shu-Chun Chen, et al.Neuropharmacology|July 7, 2019
BPR1M97, a dual mu opioid receptor/nociceptin-orphanin FQ peptide receptor agonist, produces potent antinociceptive effects with safer properties than morphinePo-Kuan Chao, Hsiao-Fu Chang, Wan-Ting Chang, et al.Scientific Reports|February 22, 2019
Convallatoxin enhance the ligand-induced mu-opioid receptor endocytosis and attenuate morphine antinociceptive tolerance in micePo-Kuan Chao, Hsiao-Fu Chang, Li-Chin Ou, et al.Anesthesiology|February 18, 2017
1-(2,4-Dibromophenyl)-3,6,6-trimethyl-1,5,6,7-tetrahydro-4H-indazol-4-one: A Novel Opioid Receptor Agonist with Less Accompanying Gastrointestinal Dysfunction than MorphinePo-Kuan Chao, Shau-Hua Ueng, Li-Chin Ou, et al.European Journal of Medicinal Chemistry|October 25, 2016
Discovery, structure-activity relationship studies, and anti-nociceptive effects of N-(1,2,3,4-tetrahydro-1-isoquinolinylmethyl)benzamides as novel opioid receptor agonistsSheng-Ren Chen, Yi-Yu Ke, Teng-Kuang Yeh, et al.European Journal of Medicinal Chemistry|February 19, 2019
The in vivo antinociceptive and μ-opioid receptor activating effects of the combination of N-phenyl-2',4'-dimethyl-4,5'-bi-1,3-thiazol-2-amines and naloxoneShu-Yu Lin, Yu-Hsien Kuo, Ya-Wen Tien, et al.Therapeutic Advances in Drug Safety|December 12, 2025
Interdisciplinary pharmaceutical care model engaging patient participation alleviate the anticholinergic burden in community-dwelling older adults: subgroup analysis of a randomized controlled trialLi-Yu Chen, Ling-Chiao Liao, Chin-Ju Chuang, et al.Journal of Cellular and Molecular Medicine|July 17, 2020
Progesterone receptor membrane component 1 is involved in oral cancer cell metastasisHsun-Yu Huang, Hsiu-Chuan Chou, Ching-Hsuan Law, et al.Pageof 6